 |
Previous Article | Next Article 
The Journal of Neuroscience, March 1, 2002, 22(5):1868-1873
Signaling Mechanisms of Metabotropic Glutamate Receptor 5 Subtype
and Its Endogenous Role in a Locomotor Network
Petronella
Kettunen,
Patrik
Krieger,
Dietmar
Hess, and
Abdeljabbar
El Manira
Nobel Institute for Neurophysiology, Department of Neuroscience,
Retzius Laboratory, Karolinska Institutet, S-171 77 Stockholm, Sweden
 |
ABSTRACT |
Metabotropic glutamate receptors (mGluRs) act as modulators in the
CNS of vertebrates, but their role in motor pattern
generation in particular is primarily unknown. The intracellular
signaling mechanisms of the group I mGluRs (mGluR1 and mGluR5), and
their endogenous role in regulating locomotor pattern generation have been investigated in the spinal cord of the lamprey. Application of the
group I mGluR agonist (R,S)-3,5-dihydroxyphenylglycine (DHPG) produced oscillations of the intracellular
Ca2+ concentration
([Ca2+]i) in neurons. The
oscillations were blocked by the mGluR5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) but not by the mGluR1 antagonist 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl
ester. These [Ca2+]i
oscillations were abolished by a phospholipase C blocker and after depletion of internal Ca2+ stores by
thapsigargin but did not involve protein kinase C activation. Furthermore, they were dependent on Ca2+ influx,
because no [Ca2+]i oscillations were
produced by DHPG in a Ca2+-free solution or after
blockade of L-type Ca2+ channels. The
mGluR5 is activated by an endogenous release of glutamate
during locomotion, and a receptor blockade by MPEP caused an increase
in the burst frequency. Thus, our results show that mGluR5 induces
[Ca2+]i oscillations and regulates the
activity of locomotor networks through endogenous activation.
Key words:
mGluR5; locomotion; spinal cord; modulation; glutamate; lamprey
 |
INTRODUCTION |
The generation of coordinated motor
patterns involves not only the fast-acting ionotropic receptors but
also the relatively slow metabotropic receptors. The role of ionotropic
glutamate receptors in spinal locomotor networks has been studied
extensively (Cazalets et al., 1992 ; Grillner et al., 1998 ; Reith and
Sillar, 1998 ; Kiehn et al., 2000 ). However, there is limited knowledge about the contribution of metabotropic glutamate receptors (mGluRs) in
locomotor pattern generation. mGluRs with pharmacological
characteristics corresponding to groups I, II, and III exist in the
lamprey, a lower vertebrate experimental model (Krieger et al., 1996 ,
1998 ; Cochilla and Alford, 1998 ). Activation of postsynaptic group I mGluRs can increase intracellular calcium concentration
([Ca2+]i),
potentiate NMDA-induced responses, and modulate the frequency of the
locomotor rhythm (Krieger et al., 2000 ). These mGluRs appear not to
have a major role in the generation of the basic locomotor rhythm, but
they play a role in its modulation (Krieger et al., 1998 ).
This group consists of two receptor subtypes (mGluR1 and mGluR5) that
elevate the levels of inositol triphosphate (IP3)
through the activation of phospholipase C (PLC) (Pin and Duvoisin,
1995 ; Anwyl, 1999 ; Fagni et al., 2000 ). Although these two subtypes commonly use a similar signal transduction pathway, their activation may result in different patterns of the
[Ca2+]i response.
In expression systems, mGluR1 elicits a single-peaked nonoscillatory
[Ca2+]i response,
whereas mGluR5 elicits oscillations (Kawabata et al., 1996 ; Nakanishi
et al., 1998 ). In contrast, an activation of native mGluR5 in neurons
induces different cellular effects. In hippocampus neurons, mGluR5
elicits a single-peaked
[Ca2+]i response
(Rae et al., 2000 ), whereas it induces
[Ca2+]i
oscillations in the neocortex (Flint et al., 1999 ). In neurons of the
subthalamic nucleus, mGluR5 potentiates NMDA receptor currents (Awad et
al., 2000 ).
In this study, we investigated which group I mGluR subtype mediates the
[Ca2+]i increase
and the underlying intracellular signal transduction pathway. We also
compared the pharmacology of this subtype with that inducing the
potentiation of NMDA responses. Finally, we examined whether the group
I mGluR subtype mediating a
[Ca2+]i increase
is endogenously activated during locomotion. Our results show that
activation of mGluR5 induces
[Ca2+]i
oscillations that do not require protein kinase C (PKC) activation, but
depend on Ca2+ entry through
L-type channels. Thus, in lamprey spinal cord neurons the
two subtypes of group I mGluRs have different cellular effects; mGluR1
potentiates NMDA receptors and mGluR5 induces
[Ca2+]i
oscillations. These two receptor subtypes are activated by endogenous
release of glutamate during locomotion and mediate opposite effects on
the frequency of the locomotor rhythm.
 |
MATERIALS AND METHODS |
Cell dissociation. Larval lampreys (Petromyzon
marinus) were anesthetized with tricaine methane sulfonate (MS222;
100 mg/l) and the spinal cord was isolated in cooled oxygenated
physiological solution. To identify motoneurons (MNs),
fluorescein-coupled dextran amine (FDA) was applied before dissociation
into muscle tissue along the entire length of the preparation after
cutting all dorsal roots to allow the transport of the dye only through
the ventral roots, thus retrogradely labeling MNs. The dissociation was
performed in Leibovitz's L-15 culture medium (Sigma, St. Louis, MO)
supplemented with penicillin-streptomycin (2 µl/ml), with the
osmolarity adjusted to 270 mOsm (El Manira and Bussières, 1997 ).
The spinal cord was incubated for 30 min in collagenase (1 mg/ml;
Sigma) and then in protease for 45 min (2 mg/ml; Sigma). The tissue was
subsequently washed with the culture medium and triturated through a
sterilized pipette. The supernatant containing the dissociated cells
was distributed in 10-12 Petri dishes (35 mm) and incubated at
10-12°C for 1-4 d.
Calcium imaging. Before calcium imaging, the dissociated
cells were incubated at room temperature for 1-2 hr with
Fluo-4/acetoxymethyl (AM) (5 µM;
Molecular Probes, Eugene, OR) added to the medium. The same
procedure was used to load FDA-labeled MNs with Fluo-4/AM after identification. After removal of the incubation medium, the cells
were perfused with a solution containing (in mM):
124 NaCl, 2 KCl, 1.2 MgCl2, 5 CaCl2, 10 glucose, and 10 HEPES, with pH adjusted
to 7.6. The following drugs were tested:
(R,S)-3,5-dihydroxyphenylglycine (DHPG),
7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylate ethyl ester
(CPCCOEt), 2-methyl-6-(phenylethynyl)pyridine (MPEP), thapsigargin, 1-(5-isoquinolinesulfonyl)-2-methylpiperazine (H-7), ryanodine, nimodipine, staurosporine, and -conotoxin GVIA ( -CgTx).
DHPG, CPCCOEt, and MPEP were purchased from Tocris Cookson (Bristol, UK). Thapsigargin, H-7, ryanodine, and nimodipine were purchased from
Research Biochemicals (Natick, MA); staurosporine and U-73122 were
supplied by Labkemi (Stockholm, Sweden); and -CgTx was obtained from
Peptides International (Herts, UK). Unless stated
otherwise, DHPG was added to the perfusing solution for 3 min at a
concentration of 100 µM. The effect of CPCCOEt,
MPEP, thapsigargin, H-7, ryanodine, staurosporine, and nimodipine on
the DHPG-induced
[Ca2+]i response
was tested using two parallel series of cultured neurons from the same
dissociation, one representing controls and the other preincubated with
the different drugs.
The 488 nm line of an argon laser was used for excitation of Fluo-4/AM
with an emission filter passing wavelengths of >515 nm. The loaded
cells were visualized using a confocal laser scanner (Odyssey; Noran
Instruments, Middleton, WI) with 10× (0.25 NA) or 20× (0.40 NA)
objectives (Nikon, Tokyo, Japan) attached to a Nikon Diaphot inverted
microscope. Brightness-over-time plots were generated by sampling
(7-15 Hz) the averaged intensity within a manually specified region of
interest within the cell soma. Analyses of the brightness-over-time
data were performed with pClamp (Axon Instruments, Foster City, CA).
The imaging experiments were typically done on three to seven cells in
each dish, in the same field of view, and on several dishes from the
same dissociation. The unidentified neurons included in this study were
monopolar and had a small diameter corresponding primarily to MNs and
interneurons. The mechanosensory dorsal root ganglion cells were not
included. Changes in fluorescence ( F), which is a
measure of changed intracellular calcium concentration, were normalized
to the resting fluorescence levels
(Frest) of the cells, and the
fluorescence from a region that did not include dye-filled neurons
(Fbackground) was subtracted. Thus,
the fluorescence data are presented as F/F = F/(Frest Fbackground). The percentage values
reported in the text and figures were calculated as the average of the
number of cells with DHPG-induced calcium oscillations per total number
of cells in that particular dish. The data are presented as means ± SD; n = the total number of neurons tested.
When two parallel series of cultured cells were used, the difference
between the proportion of cells displaying calcium oscillations in
control dishes and in preincubated dishes was tested with Fisher's exact test to determine any relationship between the two experimental conditions. The reported p value is double the single-sided
p. Fisher's exact test was performed with an on-line
calculator provided by SISA
(http://home.clara.net/sisa/binomial.htm). When the same cells were used as controls and test subjects, the statistical significance was tested with McNemar's test to compare paired groups,
performed with an on-line calculator provided by GraphPad (GraphPad
Software, San Diego, CA).
Electrophysiology. Whole-cell recordings were performed from
neurons in culture using an Axopatch 200A patch-clamp amplifier (Axon
Instruments). The cells were perfused through a gravity-driven multibarreled microperfusion system placed close to the recorded cell.
Neurons had a resting membrane potential between 60 and 55 mV. The
effect of DHPG was tested in control solution and in the presence of
the mGluR1 antagonist CPCCOEt. The control solution contained (in
mM): 124 NaCl, 2 KCl, 1.2 MgCl2, 5 CaCl2, 10 glucose,
and 10 HEPES, with pH adjusted to 7.6. For whole-cell recordings, the
pipettes were filled with a solution containing (in
mM): 113 KCH3SO3, 1.2 MgCl2, 10 glucose, and 10 HEPES, with pH adjusted
to 7.6 with KOH. Data acquisition and analysis were performed with
pClamp software.
Extracellular measurements of ventral root activity were performed on
the isolated spinal cord in vitro. The preparation was mounted in a cooled (8-12°C) homemade Sylgard-lined chamber
that was continuously perfused with an extracellular solution of the following composition (in mM): 138 NaCl, 2.1 KCl,
1.8 CaCl2, 1.2 MgCl2, 4 glucose, 2 HEPES, and 0.5 L-glutamine, bubbled
with O2, pH adjusted to 7.4. Fictive locomotion
was induced by bath application of NMDA (100 µM). The cycle duration was calculated as the
time between midpoints of two successive bursts and averaged over
60-120 cycles. In these experiments, n = the number of
animals. The analysis of the locomotor rhythm was performed with
DATA-PAC (Run Technologies, Laguna Hills, CA).
 |
RESULTS |
mGluR5 activation causes calcium oscillations in spinal
cord neurons
The group I mGluR agonist DHPG (100 µM) was applied
to lamprey spinal cord neurons loaded with Fluo-4/AM. On average,
83.2 ± 27.0% of the neurons in a single dish (n = 150; 35 dishes) exhibited oscillations in the intracellular free
calcium concentration
([Ca2+]i) (Fig.
1). Figure 1A shows the
changes in [Ca2+]i
in a single neuron loaded with Fluo-4/AM as revealed by the change in
fluorescence during the application of DHPG. The different images were
acquired at 0, 10, 30, and 40 sec. The fluorescence pattern revealed
that DHPG induced
[Ca2+]i
oscillations (Fig. 1A,B), with the first and third
frames showing low
[Ca2+]i, whereas
the second and fourth frames display high
[Ca2+]i. The
oscillatory response normally lasted during the entire recording
period, occurred in a range from 0.2 to 4 min after the start of DHPG
application, and was also elicited by consecutive applications of the
agonist (Fig. 1B). The frequency of the DHPG-induced [Ca2+]i
oscillatory response showed a large variation between neurons and
ranged between 0.005 and 0.033 Hz (n = 150). Identified
FDA-labeled MNs also showed
[Ca2+]i
oscillations in response to DHPG (n = 9 of 11; eight
dishes).

View larger version (23K):
[in this window]
[in a new window]
|
Figure 1.
DHPG-induced
[Ca2+]i oscillations in lamprey spinal
cord neurons are mediated by MPEP-sensitive, CPCCOEt-insensitive group
I mGluRs. A, Images showing an example of
[Ca2+]i oscillations induced by DHPG
in a Fluo-4/AM-loaded neuron. B, The group I mGluR
agonist DHPG (100 µM) produced oscillatory
[Ca2+]i responses, which were elicited
by consecutive applications of the agonist. C, DHPG did
not induce any [Ca2+]i oscillations in
a neuron preincubated with MPEP (100 µM), whereas
reapplication of DHPG after washout of MPEP produced
[Ca2+]i oscillations.
D, Almost all neurons displayed
[Ca2+]i oscillations in response to
DHPG in the control, but fewer responded to DHPG in the presence of
MPEP. E, CPCCOEt did not block the oscillatory
[Ca2+]i response to DHPG.
|
|
The above results show that activation of group I mGluRs produces
[Ca2+]i
oscillations in lamprey spinal cord neurons. To determine the pharmacological profile of the receptors responsible for these oscillations, the mGluR1-specific antagonist CPCCOEt (Annoura et al.,
1996 ; Casabona et al., 1997 ) and mGluR5-specific antagonist MPEP
(Gasparini et al., 1999 ) were used. Figure 1C shows a neuron in which application of DHPG in the presence of MPEP did not induce any
[Ca2+]i response.
However, reapplication of DHPG after washout of MPEP elicited
[Ca2+]i
oscillations in the same cells. In total, only 17.1 ± 17.8% of
the neurons per dish (6 of 37 neurons; seven dishes) responded to DHPG
in the presence of MPEP (100 µM) (Fig.
1D). In these, cases the DHPG-induced calcium
response consisted of a single peak. After washout of MPEP, DHPG
induced [Ca2+]i
oscillations in 87.0 ± 21.1% of the neurons per dish (31 of 37 cells; seven dishes; p < 0.001 comparing the effect of
DHPG alone with that of DHPG in the presence of MPEP). The effect of CPCCOEt on DHPG-evoked
[Ca2+]i
oscillations was also examined (Fig. 1E). In control
dishes, 93.1 ± 13.7% of neurons (25 of 28; nine dishes) showed
[Ca2+]i
oscillations, compared with 92.4 ± 17.4% of neurons (33 of 35, 11 dishes) in dishes preincubated for 30 min with CPCCOEt (100 µM; p > 0.1). These results
indicate that DHPG-induced
[Ca2+]i
oscillations are attributable to an action on an MPEP-sensitive, CPCCOEt-insensitive group I mGluR (i.e., mGluR5). Application of
DHPG in the presence of CPCCOEt did not induce any change in the
membrane potential of spinal neurons in culture, recorded using
whole-cell patch clamp (data not shown). This is in accordance with the
lack of an effect of DHPG on the membrane potential of neurons recorded
in the intact spinal cord in the presence of TTX (Krieger et al.,
2000 ).
DHPG induces [Ca2+]i oscillations
by a PLC-dependent release from internal stores
The intracellular pathway underlying
[Ca2+]i
oscillations was investigated by using a PLC blocker and by depleting
the intracellular Ca2+ stores. Figure
2A shows a neuron in
which DHPG application induced an oscillatory response, which was
abolished by applying the PLC blocker U-73122 (0.5-1
µM). DHPG elicited
[Ca2+]i
oscillations in 56.3 ± 34.7% (23 of 40 cells tested;
eight dishes) of the neurons in control dishes. After a 3 min application of U-73122, oscillations occurred only in 27.0 ± 33.4% neurons (10 of 40 cells; eight dishes; p < 0.001), and after 9 min the blocker completely abolished the
oscillations in all neurons (Fig. 2B).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 2.
The [Ca2+]i
oscillations induced by DHPG are mediated through PLC activation and
require a release from intracellular stores. A, DHPG
induced [Ca2+]i oscillations in a
spinal cord neuron in controls that were abolished by the PLC blocker
U-73122 (1 µM). B, Percentage of neurons
that displayed [Ca2+]i oscillations in
response to DHPG in controls, after 3 min, and after 9 min of
application of U-73122. C, DHPG elicited
[Ca2+]i oscillations in neurons from
control dishes, whereas no oscillatory response was produced in neurons
from dishes preincubated with thapsigargin (1 µM).
|
|
The source of the calcium underlying the DHPG-induced oscillations was
examined by using thapsigargin, which depletes internal Ca2+ stores by blocking the
Ca2+ pumps (Thastrup et al., 1990 ).
Parallel series of experiments were performed on neurons from the same
dissociation; one served as a control and the other was preincubated
for 45 min with thapsigargin (1 µM). In the
controls, the application of DHPG induced
[Ca2+]i
oscillations in all neurons tested (n = 23; five
dishes), whereas no oscillations were elicited in neurons preincubated
with thapsigargin (n = 12; three dishes) (Fig.
2C). This finding suggests that these Ca2+ oscillations are mediated by release
from internal stores.
Furthermore, the DHPG-induced
[Ca2+]i
oscillations were not blocked by ryanodine (100 µM; 45 min preincubation), which blocks the ryanodine receptors at high
concentrations. DHPG induced
[Ca2+]i
oscillations in 100% of the cells in controls (n = 18;
four dishes) and in 91.7 ± 14.4% of the cells preincubated for
45 min with ryanodine (100 µM;
n = 9; four dishes; p > 0.1; data not shown).
The involvement of PKC in the signaling pathway underlying DHPG-induced
[Ca2+]i
oscillations was also tested using the PKC blockers H-7 (10 µM; 30 min preincubation) and staurosporine (2 µM; 30 min preincubation). However, the
oscillations could not be blocked by either of the two PKC inhibitors.
In controls, 55.8 ± 38.0% of the cells showed oscillations (21 of 43 cells tested; nine dishes) in comparison with 57.2 ± 30.3%
of the H-7-treated cells (8 of 17 cells tested; four dishes)
(p = 0.7). In dishes preincubated with
staurosporine, [Ca2+]i
oscillations were elicited in 77.6 ± 25.4 of the cells (22 of 27 cells tested; five dishes) compared with 71.4 ± 25.4% in controls (15 of 18 cells tested; four dishes; p > 0.1). Therefore, the oscillatory response induced by mGluR5 activation
is not mediated by ryanodine receptors and does not involve PKC
activation; thus, it may derive from the mobilization of
Ca2+ from internal stores via an
activation of IP3 receptors.
Calcium influx through L-type channels is necessary for
the production of DHPG-induced [Ca2+]i
oscillations
The importance of extracellular Ca2+
in the generation of
[Ca2+]i
oscillations by DHPG was examined using
Ca2+-free solution and antagonists of
voltage-gated Ca2+ channels. In control
dishes, DHPG induced
[Ca2+]i
oscillations, but after switching to a
Ca2+-free solution, reapplication of DHPG
did not induce any calcium response (Fig.
3A) (n = 15;
four dishes). This indicates that extracellular
Ca2+ is necessary for the production of
[Ca2+]i
oscillations in spinal cord neurons. To determine whether the extracellular Ca2+ contributes to the
generation of the DHPG response by entering through voltage-gated
channels, specific blockers were used. Parallel series of experiments
were done; one series served as a control and the other was
preincubated with Ca2+ channel
antagonists. Blockade of L-type channels by
nimodipine (10 µM) abolished the
[Ca2+]i
oscillations induced by DHPG (Fig. 3B). In control dishes, 80.0 ± 28.3% of the neurons tested (n = 10; two
dishes) exhibited oscillatory responses to DHPG application (Fig.
3C), whereas only 14.5 ± 17.1% of the neurons
preincubated with nimodipine showed [Ca2+]i
oscillations (n = 12; four dishes; p = 0.01) (Fig. 3C). Blockade of N-type channels by -CgTx (1 µM) did not affect the DHPG-induced [Ca2+]i oscillations. In control
dishes, 73.3 ± 34.1% of the neurons tested
(n = 13; three dishes) displayed
[Ca2+]i
oscillations in response to DHPG, compared with 70.0 ± 10.0% of
neurons (n = 7) in dishes (n = 3)
preincubated with -CgTx (p > 0.1) (Fig.
3C).

View larger version (26K):
[in this window]
[in a new window]
|
Figure 3.
DHPG-induced
[Ca2+]i oscillations require an influx
of extracellular Ca2+ through L-type
Ca2+ channels. A, Removal of
Ca2+ from the perfusing solution abolished the
[Ca2+]i oscillations induced by DHPG.
The illustrated neuron displayed
[Ca2+]i oscillations in response to
DHPG, but after switching to Ca2+-free solution DHPG
was unable to produce any [Ca2+]i
oscillations. B, In controls, the application of DHPG
produced [Ca2+]i oscillations, whereas
no oscillatory [Ca2+]i response was
observed in neurons preincubated with the L-type
Ca2+ channel blocker nimodipine (10 µM). C, The percentage of neurons per dish
that produced [Ca2+]i oscillations in
response to DHPG in controls and in dishes preincubated with nimodipine
and with -CgTx.
|
|
Endogenous activation of mGluR5 during locomotor
network activity
To test whether endogenously released glutamate activates this
receptor subtype during locomotion, the mGluR5 antagonist MPEP was
used. Locomotor rhythm was induced in all experiments in a spinal cord
preparation by NMDA (100 µM). An application of MPEP (50-100 µM) (Fig.
4A) reversibly
increased the frequency of the locomotor rhythm from 2.0 ± 0.2 Hz
to 2.7 ± 0.6 Hz (Fig. 4B,C) (n = 7; p < 0.05). We subsequently examined whether MPEP
affects the increase in locomotor frequency induced by the mGluR1 and mGluR5 agonist DHPG (Krieger et al., 1998 ). Figure
5 shows an experiment in which
application of DHPG increased the locomotor frequency that persisted in
the presence of MPEP. This indicates that the increase in frequency is
not mediated by mGluR5 but rather by mGluR1. This mGluR subtype is
activated by endogenously released glutamate, because application of
the mGluR1 antagonist CPCCOEt alone decreases the frequency of the
locomotor rhythm (Krieger et al., 1998 ). The DHPG-increased locomotor
frequency was not significantly (p > 0.1)
different in the controls (from 2.1 ± 0.6 Hz to 3.0 ± 0.7 Hz) and with MPEP (from 2.4 ± 0.4 Hz to 3.1 ± 0.7 Hz)
(n = 7) (Fig. 5B). Thus, these results show
that mGluR5 is activated during locomotion and that the two subtypes of
group I mGluRs produce opposite effects on the frequency of the
locomotor rhythm.

View larger version (12K):
[in this window]
[in a new window]
|
Figure 4.
mGluR5 activation by endogenously released
glutamate during locomotor network activity. A, The
mGluR5 antagonist MPEP reversibly increased the frequency of the
locomotor rhythm induced by NMDA. B, C, The increase in
locomotor frequency during MPEP application.
|
|

View larger version (31K):
[in this window]
[in a new window]
|
Figure 5.
The DHPG-induced increase in locomotor frequency
is not blocked by the mGluR5 antagonist MPEP. A, DHPG
increased locomotor frequency in control conditions and in the presence
of the mGluR5 antagonist MPEP. B, The percentage of
increase in locomotor frequency by DHPG in controls and with MPEP
application.
|
|
 |
DISCUSSION |
We have shown that activation of group I mGluRs by DHPG induces
[Ca2+]i
oscillations in lamprey spinal cord neurons. These oscillations were
blocked by the mGluR5 antagonist MPEP but not by the mGluR1 antagonist
CPCCOEt. In addition to producing
[Ca2+]i
oscillations, DHPG potentiates NMDA responses and increases the
frequency of the locomotor rhythm induced by NMDA in the intact spinal
cord of the lamprey (Krieger et al., 2000 ). The latter two effects are
blocked by CPCCOEt, which when applied alone decreases the frequency of
the locomotor rhythm. In contrast, blockade of mGluR5 by MPEP increases
the frequency (Fig. 4). Because CPCCOEt at the concentration used in
this study has been shown to block mGluR1 (Annoura et al., 1996 ;
Casabona et al., 1997 ; Litschig et al., 1999 ), whereas MPEP antagonizes
mGluR5 (Gasparini et al., 1999 ), our results show that mGluR5 induces
[Ca2+]i
oscillations and decreases locomotor frequency, whereas mGluR1 interacts with NMDA receptors and increases the frequency of the locomotor rhythm. The mGluR5 had only a nonsignificant effect on
locomotor frequency in the presence of DHPG (Fig. 5), whereas it
significantly increased the frequency by blocking the effect of the
endogenously released glutamate (Fig. 4). Thus, MPEP appears to be more
potent in blocking the activation of mGluR5 by endogenous glutamate
than by DHPG on locomotor frequency. This suggests that the
DHPG-induced modulation of the locomotor rhythm is mediated primarily
by activation of mGluR1 or that the potency of MPEP during fictive
locomotion depends on the agonist used to activate mGluR5. Such an
agonist-dependent antagonism has been shown using different antagonists
on mGluR5 in expression systems (Brabet et al., 1995 ; Doherty et al.,
1999 ).
mGluR5-mediated
[Ca2+]i
oscillations have been reported in astrocytes (Nakahara et al., 1997 )
and in developing neocortical neurons (Flint et al., 1999 ). The
underlying mechanisms have been examined previously only in transfected
cells (Kawabata et al., 1996 ). The mGluR5 possesses a regulatory PKC
phosphorylation site and is also coupled to PLC to produce both DAG and
IP3 on its activation. IP3
increases [Ca2+]i
by release of Ca2+ from internal stores,
whereas DAG leads to PKC activation that can phosphorylate mGluR5 and
thus uncouple the receptor from the intracellular transduction pathway,
leading to a decrease in
[Ca2+]i levels.
The uncoupling of the mGluR5 from PLC decreases the production of DAG
and thereby the activation of PKC and the phosphorylation of the
receptor. This enables the receptor to couple to its signal transduction pathway again, and a new cycle of
[Ca2+]i
oscillations starts. In transfected cells, the oscillations are blocked
by PKC inhibitors and persist in the presence of a Ca2+-free solution, indicating that they
are not dependent on extracellular Ca2+
(Kawabata et al., 1996 ).
Our results show that DHPG induces
[Ca2+]i
oscillations through signaling mechanisms different from those
described above. In lamprey spinal cord neurons the oscillations were
abolished in Ca2+-free solution and by a
blockade of L-type Ca2+
channels but persisted after blockade of PKC and ryanodine receptors. L-type channels in lamprey spinal cord neurons start activating at
negative voltages (El Manira and Bussières, 1997 ). The only channels that are activated at negative voltages among the cloned L-type channels are those expressed by 1D (Cav1.3) subunit.
These channels start to be activated at membrane potentials of
approximately 60 mV (Svirskis and Hounsgaard, 1997 ; Platzer et al.,
2000 ; Koschak et al., 2001 ), which correspond to the resting membrane
potential of lamprey spinal cord neurons. In imaging experiments,
application of the L-type Ca2+ channel
agonist BayK increased the basal Ca2+
level (data not shown), suggesting that in lamprey spinal cord neurons
these channels are open at the resting membrane potential and allow a
continuous small influx of Ca2+. The role
of the Ca2+ influx through L-type channels
could be to trigger Ca2+ release from
internal stores via Ca2+-induced
Ca2+ release and/or to reload the stores
after depletion. The DHPG-induced [Ca2+]i
oscillations are likely to be mediated by release from internal stores
and not through a direct action on L-type
Ca2+ channels, because DHPG did not induce
any change in the membrane potential at rest. Furthermore, the
[Ca2+]i
oscillations were blocked by a PLC inhibitor and thapsigargin, which
depletes intracellular stores by blocking the ATPase that mediates
Ca2+ reuptake into the internal stores.
These results indicate that the
[Ca2+]i
oscillations induced by DHPG in these neurons are attributable to
release of Ca2+ from internal stores
through PLC- and Ca2+-dependent
mechanisms, presumably by acting on IP3-gated
intracellular Ca2+ stores. The fact that
the mGluR1-specific antagonist CPCCOEt did not block the DHPG-induced
oscillations suggests that this receptor does not mediate
[Ca2+]i
oscillations in lamprey spinal cord neurons. Because both mGluR1 and
mGluR5 are commonly coupled to the
IP3/[Ca2+]i
signal transduction pathway, they are both expected to release Ca2+ from internal stores. However, this
appears not to be the case in these neurons. A possible explanation
could be that the strength of hydrolysis of polyphosphoinositide (PPI)
is different for the MPEP-sensitive and CPCCOEt-sensitive group I
mGluRs found in lamprey spinal cord neurons. Such a difference has been
shown in the rat brain, in which mGluR1 couples less efficiently than
mGluR5 to PPI hydrolysis (Casabona et al., 1997 ). Thus, our results
show the existence of Ca2+-dependent
[Ca2+]i
oscillations induced by a group I mGluR, with a pharmacological profile
similar to mGluR5.
[Ca2+]i
oscillations can be transduced into specific signals that may regulate
the activity of spinal cord neurons. Ca2+
can activate a wide range of
Ca2+-sensitive enzymes such as calmodulin
kinase II (De Koninck and Schulman, 1998 ), gene regulation
(Greenberg et al., 1992 ), or Ca2+-dependent ion channels (e.g.,
KCa) (Fiorillo and Williams, 1998 ). It
has been shown recently in ventral midbrain dopamine neurons that the
mGluR1-induced increase in
[Ca2+]i activates
an apamin-sensitive KCa
conductance, leading to a slow IPSP (Fiorillo and Williams, 1998 ).
Activation of mGluR5 by DHPG in the presence of the mGluR1 antagonist
CPCCOEt did not induce any changes in the membrane potential of spinal
cord neurons in culture. Furthermore, we have shown previously that
application of DHPG in the presence of TTX had no effect on the
membrane potential of neurons in the intact spinal cord (Krieger et
al., 2000 ). Together these results suggest that the
[Ca2+]i increase
induced by mGluR5 is not coupled to the activation of
Ca2+-dependent channels.
An important finding of this study is that mGluR5 does not serve
similar roles as mGluR1 in the lamprey locomotor network. Regardless of
whether the increase in the burst frequency can be accounted for by the
interaction between mGluR1 and NMDA receptors (Krieger et al., 2000 ),
the mechanisms by which mGluR5 decreases the frequency are not fully
determined. However, because
[Ca2+]i
oscillation is the only cellular response induced by mGluR5 activation
in lamprey spinal cord neurons, these oscillations might regulate the
frequency of the locomotor rhythm by activating intracellular messenger pathways.
 |
FOOTNOTES |
Received July 24, 2001; revised Dec. 4, 2001; accepted Dec. 10, 2001.
This work was supported by the Swedish Research Council (project
11562), the Swedish Foundation for Strategic Research, the A. Eriksson
Foundation, the Å. Wiberg Foundation, the Swedish Society for
Medicine, and the Karolinska Institutet funds. P. Krieger received a
fellowship from the Knut and Alice Wallenberg Foundation. D.H. received
a fellowship from the Deutsche Forschungsgemeinschaft, Germany. We
thank Drs. S. Grillner, D. Parker, and P. Wallén for their
comments on this manuscript. We are also grateful to H. Axegren and M. Bredmyr for excellent technical assistance.
Correspondence should be addressed to A. El Manira, Nobel Institute for
Neurophysiology, Department of Neuroscience, Karolinska Institutet,
S-171 77 Stockholm, Sweden. E-mail: abdel.elmanira{at}neuro.ki.se.
 |
REFERENCES |
-
Annoura H,
Fukunaga A,
Uesugi M,
Tatsuoka T,
Horikawa Y
(1996)
A novel class of antagonists for metabotropic glutamate receptors, 7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxylates.
Bioorg Med Chem Lett
6:763-766.
-
Anwyl R
(1999)
Metabotropic glutamate receptors: electrophysiological properties and role in plasticity.
Brain Res Brain Res Rev
29:83-120[Medline].
-
Awad H,
Hubert GW,
Smith Y,
Levey AI,
Conn PJ
(2000)
Activation of metabotropic glutamate receptor 5 has direct excitatory effects and potentiates NMDA receptor currents in neurons of the subthalamic nucleus.
J Neurosci
20:7871-7879[Abstract/Free Full Text].
-
Brabet I,
Mary S,
Bockaert J,
Pin JP
(1995)
Phenylglycine derivatives discriminate between mGluR1- and mGluR5-mediated responses.
Neuropharmacology
34:895-903[ISI][Medline].
-
Casabona G,
Knopfel T,
Kuhn R,
Gasparini F,
Baumann P,
Sortino MA,
Copani A,
Nicoletti F
(1997)
Expression and coupling to polyphosphoinositide hydrolysis of group I metabotropic glutamate receptors in early postnatal and adult rat brain.
Eur J Neurosci
9:12-17[ISI][Medline].
-
Cazalets JR,
Sqalli-Houssaini Y,
Clarac F
(1992)
Activation of the central pattern generators for locomotion by serotonin and excitatory amino acids in neonatal rat.
J Physiol (Lond)
455:187-204[Abstract/Free Full Text].
-
Cochilla AJ,
Alford S
(1998)
Metabotropic glutamate receptor-mediated control of neurotransmitter release.
Neuron
20:1007-1016[ISI][Medline].
-
De Koninck P,
Schulman H
(1998)
Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations.
Science
279:227-230[Abstract/Free Full Text].
-
Doherty AJ,
Collingridge GL,
Jane DE
(1999)
Antagonist activity of alpha-substituted 4-carboxyphenylglycine analogues at group I metabotropic glutamate receptors expressed in CHO cells.
Br J Pharmacol
126:205-210[ISI][Medline].
-
El Manira A,
Bussières N
(1997)
Calcium channel subtypes in lamprey sensory and motor neurons.
J Neurophysiol
78:1334-1340[Abstract/Free Full Text].
-
Fagni L,
Chavis P,
Ango F,
Bockaert J
(2000)
Complex interactions between mGluRs, intracellular Ca2+ stores and ion channels in neurons.
Trends Neurosci
23:80-88[ISI][Medline].
-
Fiorillo CD,
Williams JT
(1998)
Glutamate mediates an inhibitory postsynaptic potential in dopamine neurons.
Nature
394:78-82[Medline].
-
Flint AC,
Dammerman RS,
Kriegstein AR
(1999)
Endogenous activation of metabotropic glutamate receptors in neocortical development causes neuronal calcium oscillations.
Proc Natl Acad Sci USA
96:12144-12149[Abstract/Free Full Text].
-
Gasparini F,
Lingenhohl K,
Stoehr N,
Flor PJ,
Heinrich M,
Vranesic I,
Biollaz M,
Allgeier H,
Heckendorn R,
Urwyler S,
Varney MA,
Johnson EC,
Hess SD,
Rao SP,
Sacaan AI,
Santori EM,
Velicelebi G,
Kuhn R
(1999)
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
Neuropharmacology
38:1493-1503[ISI][Medline].
-
Greenberg ME,
Thompson MA,
Sheng M
(1992)
Calcium regulation of immediate early gene transcription.
J Physiol (Paris)
86:99-108[Medline].
-
Grillner S,
Ekeberg Ö,
El Manira A,
Lansner A,
Parker D,
Tegnér J,
Wallén P
(1998)
Intrinsic function of a neuronal network: a vertebrate central pattern generator.
Brain Res Brain Res Rev
26:184-197[Medline].
-
Kawabata S,
Tsutsumi R,
Kohara A,
Yamaguchi T,
Nakanishi S,
Okada M
(1996)
Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors.
Nature
383:89-92[Medline].
-
Kiehn O,
Kjaerulff O,
Tresch MC,
Harris-Warrick RM
(2000)
Contributions of intrinsic motor neuron properties to the production of rhythmic motor output in the mammalian spinal cord.
Brain Res Bull
53:649-659[ISI][Medline].
-
Koschak A,
Reimer D,
Huber I,
Grabner M,
Glossmann H,
Engel J,
Striessnig J
(2001)
1D (Cav1.3) subunits can form L-type Ca2+ channels activating at negative voltages.
J Biol Chem
276:22100-22106[Abstract/Free Full Text]. -
Krieger P,
El Manira A,
Grillner S
(1996)
Activation of pharmacologically distinct metabotropic glutamate receptors depresses reticulospinal-evoked monosynaptic EPSPs in the lamprey spinal cord.
J Neurophysiol
76:3834-3841[Abstract/Free Full Text].
-
Krieger P,
Grillner S,
El Manira A
(1998)
Endogenous activation of metabotropic glutamate receptors contributes to burst frequency regulation in the lamprey locomotor network.
Eur J Neurosci
10:3333-3342[ISI][Medline].
-
Krieger P,
Hellgren-Kotaleski J,
Kettunen P,
El Manira A
(2000)
Interaction between metabotropic and ionotropic glutamate receptors regulates neuronal network activity.
J Neurosci
20:5382-5391[Abstract/Free Full Text].
-
Litschig S,
Gasparini F,
Rueegg D,
Stoehr N,
Flor PJ,
Vranesic I,
Prezeau L,
Pin JP,
Thomsen C,
Kuhn R
(1999)
CPCCOEt, a noncompetitive metabotropic glutamate receptor 1 antagonist, inhibits receptor signaling without affecting glutamate binding.
Mol Pharmacol
55:453-461[Abstract/Free Full Text].
-
Nakahara K,
Okada M,
Nakanishi S
(1997)
The metabotropic glutamate receptor mGluR5 induces calcium oscillations in cultured astrocytes via protein kinase C phosphorylation.
J Neurochem
69:1467-1475[ISI][Medline].
-
Nakanishi S,
Nakajima Y,
Masu M,
Ueda Y,
Nakahara K,
Watanabe D,
Yamaguchi S,
Kawabata S,
Okada M
(1998)
Glutamate receptors: brain function and signal transduction.
Brain Res Brain Res Rev
26:230-235[Medline].
-
Pin JP,
Duvoisin R
(1995)
The metabotropic glutamate receptors: structure and functions.
Neuropharmacology
34:1-26[ISI][Medline].
-
Platzer J,
Engel J,
Schrott-Fischer A,
Stephan K,
Bova S,
Chen H,
Zheng H,
Striessnig J
(2000)
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels.
Cell
102:89-97[ISI][Medline].
-
Rae MG,
Martin DJ,
Collingridge GL,
Irving AJ
(2000)
Role of Ca2+ stores in metabotropic L-glutamate receptor-mediated supralinear Ca2+ signaling in rat hippocampal neurons.
J Neurosci
20:8628-8636[Abstract/Free Full Text].
-
Reith CA,
Sillar KT
(1998)
A role for slow NMDA receptor-mediated, intrinsic neuronal oscillations in the control of fast fictive swimming in Xenopus laevis larvae.
Eur J Neurosci
10:1329-1340[ISI][Medline].
-
Svirskis G,
Hounsgaard J
(1997)
Depolarization-induced facilitation of a plateau-generating current in ventral horn neurons in the turtle spinal cord.
J Neurophysiol
78:1740-1742[Abstract/Free Full Text].
-
Thastrup O,
Cullen PJ,
Drobak BK,
Hanley MR,
Dawson AP
(1990)
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2+-ATPase.
Proc Natl Acad Sci USA
87:2466-2470[Abstract/Free Full Text].
Copyright © 2002 Society for Neuroscience 0270-6474/02/2251868-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
P. Wallen, B. Robertson, L. Cangiano, P. Low, A. Bhattacharjee, L. K. Kaczmarek, and S. Grillner
Sodium-dependent potassium channels of a Slack-like subtype contribute to the slow afterhyperpolarization in lamprey spinal neurons
J. Physiol.,
November 15, 2007;
585(1):
75 - 90.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kyriakatos and A. El Manira
Long-Term Plasticity of the Spinal Locomotor Circuitry Mediated by Endocannabinoid and Nitric Oxide Signaling
J. Neurosci.,
November 14, 2007;
27(46):
12664 - 12674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Levi and A. I. Selverston
Mechanisms Underlying Type I mGluR-Induced Activation of Lobster Gastric Mill Neurons
J Neurophysiol,
December 1, 2006;
96(6):
3378 - 3388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nistri, K. Ostroumov, E. Sharifullina, and G. Taccola
Tuning and playing a motor rhythm: how metabotropic glutamate receptors orchestrate generation of motor patterns in the mammalian central nervous system
J. Physiol.,
April 15, 2006;
572(2):
323 - 334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-J. I. Jong, V. Kumar, A. E. Kingston, C. Romano, and K. L. O'Malley
Functional Metabotropic Glutamate Receptors on Nuclei from Brain and Primary Cultured Striatal Neurons: ROLE OF TRANSPORTERS IN DELIVERING LIGAND
J. Biol. Chem.,
August 26, 2005;
280(34):
30469 - 30480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Verkhratsky
Physiology and Pathophysiology of the Calcium Store in the Endoplasmic Reticulum of Neurons
Physiol Rev,
January 1, 2005;
85(1):
201 - 279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Kettunen, D. Hess, and A. E. Manira
mGluR1, But Not mGluR5, Mediates Depolarization of Spinal Cord Neurons by Blocking a Leak Current
J Neurophysiol,
October 1, 2003;
90(4):
2341 - 2348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. O'Malley, Y.-J. I. Jong, Y. Gonchar, A. Burkhalter, and C. Romano
Activation of Metabotropic Glutamate Receptor mGlu5 on Nuclear Membranes Mediates Intranuclear Ca2+ Changes in Heterologous Cell Types and Neurons
J. Biol. Chem.,
July 18, 2003;
278(30):
28210 - 28219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Alford, E. Schwartz, and G. V. Di Prisco
The Pharmacology of Vertebrate Spinal Central Pattern Generators
Neuroscientist,
June 1, 2003;
9(3):
217 - 228.
[Abstract]
[PDF]
|
 |
|
|